Wave Life Sciences Book Value Per Share Growth & History (WVE)
Wave Life Sciences's book value per share was $2.76 for fiscal 2025.
View full Wave Life Sciences company overviewWave Life Sciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.76 | $1.39 | +101.76% |
| 2024 | 2024-12-31 | $1.37 | $1.04 | +311.65% |
| 2023 | 2023-12-31 | $0.33 | $0.85 | — |
| 2022 | 2022-12-31 | -$0.52 | -$1.06 | — |
| 2021 | 2021-12-31 | $0.54 | -$1.15 | −68.00% |
| 2020 | 2020-12-31 | $1.70 | -$0.16 | −8.56% |
| 2019 | 2019-12-31 | $1.86 | -$0.63 | −25.43% |
| 2018 | 2018-12-31 | $2.49 | -$2.53 | −50.39% |
| 2017 | 2017-12-31 | $5.02 | -$0.71 | −12.41% |
| 2016 | 2016-12-31 | $5.73 | -$1.39 | −19.58% |
| 2015 | 2015-12-31 | $7.12 | $8.49 | — |
| 2014 | 2014-12-31 | -$1.37 | $3.08 | — |
| 2013 | 2013-12-31 | -$4.45 | — | — |
Wave Life Sciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.35 | $1.45 | +162.29% |
| Q1 2026 | 2026-03-31 | $2.66 | $1.55 | +138.63% |
| Q4 2025 | 2025-12-31 | $2.76 | $1.39 | +101.76% |
| Q3 2025 | 2025-09-30 | $0.78 | -$0.18 | −18.59% |
| Q2 2025 | 2025-06-30 | $0.89 | $0.92 | — |
| Q1 2025 | 2025-03-31 | $1.11 | $0.91 | +437.16% |
| Q4 2024 | 2024-12-31 | $1.37 | $1.04 | +311.65% |
| Q3 2024 | 2024-09-30 | $0.95 | $1.36 | — |
| Q2 2024 | 2024-06-30 | -$0.03 | $0.50 | — |
| Q1 2024 | 2024-03-31 | $0.21 | $0.56 | — |
| Q4 2023 | 2023-12-31 | $0.33 | $0.85 | — |
| Q3 2023 | 2023-09-30 | -$0.41 | -$0.36 | — |
| Q2 2023 | 2023-06-30 | -$0.52 | -$0.88 | — |
| Q1 2023 | 2023-03-31 | -$0.35 | -$0.35 | — |
| Q4 2022 | 2022-12-31 | -$0.52 | -$1.06 | — |
| Q3 2022 | 2022-09-30 | -$0.05 | -$0.63 | — |
| Q2 2022 | 2022-06-30 | $0.36 | -$0.08 | −17.37% |
| Q1 2022 | 2022-03-31 | -$0.00 | -$1.06 | — |
| Q4 2021 | 2021-12-31 | $0.54 | -$1.15 | −68.00% |
| Q3 2021 | 2021-09-30 | $0.58 | -$1.64 | −74.09% |
| Q2 2021 | 2021-06-30 | $0.43 | $0.56 | — |
| Q1 2021 | 2021-03-31 | $1.06 | $0.46 | +75.76% |
| Q4 2020 | 2020-12-31 | $1.70 | -$0.16 | −8.56% |
| Q3 2020 | 2020-09-30 | $2.22 | -$1.13 | −33.70% |
| Q2 2020 | 2020-06-30 | -$0.13 | -$4.80 | — |
| Q1 2020 | 2020-03-31 | $0.60 | -$5.14 | −89.51% |
| Q4 2019 | 2019-12-31 | $1.86 | -$0.63 | −25.43% |
| Q3 2019 | 2019-09-30 | $3.35 | -$0.28 | −7.59% |
| Q2 2019 | 2019-06-30 | $4.68 | -$0.08 | −1.67% |
| Q1 2019 | 2019-03-31 | $5.75 | $1.82 | +46.18% |
| Q4 2018 | 2018-12-31 | $2.49 | -$2.53 | −50.39% |
| Q3 2018 | 2018-09-30 | $3.62 | -$2.35 | −39.35% |
| Q2 2018 | 2018-06-30 | $4.76 | -$2.06 | −30.20% |
| Q1 2018 | 2018-03-31 | $3.93 | -$1.04 | −20.93% |
| Q4 2017 | 2017-12-31 | $5.02 | -$0.71 | −12.41% |
| Q3 2017 | 2017-09-30 | $5.97 | -$0.47 | −7.23% |
| Q2 2017 | 2017-06-30 | $6.81 | -$0.28 | −4.00% |
| Q1 2017 | 2017-03-31 | $4.97 | -$1.83 | −26.87% |
| Q4 2016 | 2016-12-31 | $5.73 | -$1.39 | −19.58% |
| Q3 2016 | 2016-09-30 | $6.44 | $6.78 | — |
| Q2 2016 | 2016-06-30 | $7.10 | — | — |
| Q1 2016 | 2016-03-31 | $6.80 | — | — |
| Q4 2015 | 2015-12-31 | $7.12 | $8.49 | — |
| Q3 2015 | 2015-09-30 | -$0.34 | — | — |
| Q4 2014 | 2014-12-31 | -$1.37 | — | — |
Wave Life Sciences book value per share trends
Over the last five fiscal years, Wave Life Sciences's book value per share increased from $1.70 to $2.76, a change of $1.07. The latest reported quarter, Q2 2026, shows $2.35.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Wave Life Sciences source filings ↗